Request Your Free White Paper Now:

"Driving Affordability: The FinaBio Success Story in Conjugate Vaccine Manufacturing"

Download this White Paper

Fina Biosolutions (FinaBio) has a clear mission: Make conjugate vaccines more affordable. FinaBio is unique in that it is a privately held, self-funded biotechnology company. The company needed to implement key strategies and solutions for cGMP manufacturing of EcoCRM®, FinaBio’s CRM197 (genetically detoxified diphtheria toxin) which is globally used as the carrier protein in conjugate vaccines.

Download this insightful article to learn more about their success story. Learn about:

• How to leverage customized, flexible partnerships to drive affordability
• Ways to ensure long-term supply security
• The big impact small biotech companies are making within the industry
• And more

Offered Free by: Scorpius BioManufacturing
See All Resources from: Scorpius BioManufacturing